ArticleScientific reports2026
Integrated transcriptomic analysis of the temporal cortex identifies CRH and GAD2 as neuropathological markers and reveals altered immune microenvironment in Alzheimer's disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention.Frontiers in immunology · 2026Article
- Association between Alzheimer's disease and MHC-I antigen processing and presentation pathway: a narrative review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by complex neuroimmune interactions. Identifying reliable neuropathological markers and understanding immune cell infiltration in the brain are essential for improving our understanding of AD pathology. We integrated four temporal cortex gene expression datasets from the GEO database (GSE36980, GSE37263, GSE118553, GSE122063). Differentially expressed genes (DEGs) were identified using RobustRankAggreg (RRA) and batch correction. Functional enrichment was analyzed via GO and KEGG, and hub genes were identified through protein-protein interaction networks and comparative intersection analysis. Diagnostic performance was evaluated using ROC curves, and immune cell infiltration was profiled with CIBERSORT, with significant immune subsets identified via Wilcoxon tests and LASSO regression. Analysis revealed 98 robust DEGs, prominently enriched in pathways related to synaptic transmission and neuroactive ligand-receptor interactions. Two hub genes, CRH and GAD2, were identified and validated as being significantly downregulated in AD. ROC analysis affirmed their high discriminatory value (AUC ≥ 0.7), with a combined model demonstrating good performance. Immune infiltration profiling in the AD temporal cortex uncovered significant alterations in six immune cell populations: M2 macrophages, activated dendritic cells, and resting mast cells were increased, while plasma cells, regulatory T cells (Tregs), and activated NK cells were decreased. However, no significant correlation was found between the expression of CRH/GAD2 and these immune cell alterations. CRH and GAD2 are potential neuropathological markers for AD. The distinct immune infiltration patterns observed highlight the involvement of both innate and adaptive immunity in AD pathogenesis, offering new insights for understanding AD pathology and informing future therapeutic strategies. The lack of direct correlation suggests that neuronal gene dysregulation and immune alterations may represent parallel or independently regulated pathological dimensions in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.